Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

cAMP-PKA cascade: An outdated topic for depression?
Feng Gao, Shaojie Yang, Juan Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113030-113030
Open Access | Times Cited: 51
Antidepressants and quality of life in patients with major depressive disorder – Systematic review and meta‐analysis of double‐blind, placebo‐controlled RCTs
Teresa Wiesinger, Stefanie Kremer, Tom Bschor, et al.
Acta Psychiatrica Scandinavica (2023) Vol. 147, Iss. 6, pp. 545-560
Open Access | Times Cited: 15
Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov
Eugenia D. Namiot, Diana Smirnovová, Aleksandr V. Sokolov, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Neuroprotective effects of gypenosides on LPS-induced anxiety and depression-like behaviors
Mei Guo, Wenjing Pei, Liming Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113367-113367
Closed Access | Times Cited: 4
Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis
Xenija Lense, Christoph Hiemke, Cleo S. M. Funk, et al.
Psychopharmacology (2023) Vol. 241, Iss. 2, pp. 275-289
Open Access | Times Cited: 7
Serotonin transporter knockdown relieves depression-like behavior and ethanol-induced CPP in mice after chronic social defeat stress
Amine Bahí
Behavioural Brain Research (2024) Vol. 466, pp. 114998-114998
Closed Access | Times Cited: 2
Dose effects of tricyclic antidepressants in the treatment of acute depression – A systematic review and meta-analysis of randomized trials
Christopher Baethge, Cora Braun, Lena Rink, et al.
Journal of Affective Disorders (2022) Vol. 307, pp. 191-198
Closed Access | Times Cited: 9
Prescription patterns in unipolar depression: A nationwide Danish register‐based study of 113,175 individuals followed for 10 years
Anders Jørgensen, Emma Neble Larsen, Mathilde Marie Brünnich Sloth, et al.
Acta Psychiatrica Scandinavica (2023) Vol. 149, Iss. 2, pp. 88-97
Closed Access | Times Cited: 5
Obligatory role of microglia-mobilized hippocampal CREB-BDNF signaling in the prophylactic effect of β-glucan on chronic stress-induced depression-like behaviors in mice
Cheng Zhao, Ruiting Shi, Xu Lu, et al.
European Journal of Pharmacology (2023) Vol. 964, pp. 176288-176288
Closed Access | Times Cited: 5
Rethinking the medication management of major depression
J. John Mann, Mina Rizk
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 4, pp. 331-363
Closed Access | Times Cited: 4
Antidepressants and Social Functioning in Patients with Major Depressive Disorder: Systematic Review and Meta-Analysis of Double-Blind, Placebo-Controlled RCTs
Stefanie Kremer, Teresa Wiesinger, Tom Bschor, et al.
Psychotherapy and Psychosomatics (2023) Vol. 92, Iss. 5, pp. 304-314
Open Access | Times Cited: 3
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 105-114
Open Access | Times Cited: 2
MCPIP1 alleviates depressive‑like behaviors in mice by inhibiting the TLR4/TRAF6/NF‑κB pathway to suppress neuroinflammation
Qi An, Jiejing Xia, Fanchun Pu, et al.
Molecular Medicine Reports (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis
Xin Tan, Yuejuan Xu, Shixin Wang, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1627-1627
Open Access | Times Cited: 2
The dose-response relationship of vortioxetine on major depressive disorder: an umbrella review
Ping Wang, Weiwei Wang, Yiqi Liu, et al.
Psychiatry Research (2024) Vol. 340, pp. 116118-116118
Open Access
The gut microbiota-brain connection: insights into major depressive disorder and bipolar disorder
Jia Zhao, Jiaoyan Liu, Jianguo Feng, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Zweitschrittverfahren in der antidepressiven Pharmakotherapie
Marlene Krabs, Tom Bschor, Jonathan Henssler, et al.
Der Nervenarzt (2024)
Closed Access
Beyond Metabolic Messengers: Bile Acids and TGR5 as Pharmacotherapeutic Intervention for Psychiatric Disorders
Arief Gunawan Darmanto, Ting‐Lin Yen, Jing‐Shiun Jan, et al.
Pharmacological Research (2024), pp. 107564-107564
Open Access
Evaluation, Treatment, and Referral of Treatment-Resistant Depression in Primary Care
Amit Chopra, James Luccarelli, Jonah N. Cohen, et al.
The Primary Care Companion For CNS Disorders (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 1
Antidepressivakombinationen in der Akuttherapie der Depression
Jonathan Henssler, Christopher Baethge
NeuroTransmitter (2023) Vol. 34, Iss. 11, pp. 38-45
Closed Access
Influencia del uso de medicamentos psicotrópicos en el aumento de resistencia Escherichia coli
Doménica Nicolle Párraga Zambrano, Lourdes Gioconda Tabares Rosero
Salud Ciencia y Tecnología (2023) Vol. 4, pp. 701-701
Open Access
Antidepressiva
Francesca Regen, Otto Benkert
Springer eBooks (2023), pp. 1-213
Closed Access
Walter H, Haaf R, Köhler S. Therapiemöglichkeiten der Depression nach Non-Response

Nervenheilkunde (2023) Vol. 42, Iss. 12, pp. 895-897
Closed Access
Page 1

Scroll to top